Shares of Bristol Myers Squibb Co. slipped 4.97% to $47.57 Tuesday, on what proved to be an all-around dismal trading ...

The funds will reportedly be allocated for R&D, technology advancements, and enhancing domestic manufacturing capacity.

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

Bristol Myers Squibb said on Monday it will invest $40 billion in the U.S. over the next five years, as it seeks to expand ...

After revealing in February plans to save $2 billion more on top of a previously disclosed cost-cutting initiative, Bristol ...

Bristol Myers Squibb plans to cut 516 jobs in NJ as part of a $2B cost-saving initiative, bringing total layoffs this year to ...

This revenue marks a 6% decline year-over-year from the same timeframe last year, during which the company recorded a loss of ...

Bristol Myers Squibb, the pharmaceutical company headquartered in New Jersey, announced plans to lay off more than 500 ...

Bristol-Myers Squibb is undervalued with a 5%+ dividend yield, robust pipeline, and recession-resistant business. Click here ...

The global pharmaceutical company will lay off 516 employees in Lawrence Township, according to a Worker Adjustment and Retraining Notification filing with the state. The cuts will hit May 9 and ...

Shares of Bristol Myers Squibb Co. BMY shed 1.01% to $50.06 Monday, on what proved to be an all-around grim trading session ...